Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Pharmala Biotech Holdings Inc. (MDMA) operate in?
Pharmala Biotech Holdings Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Pharmala Biotech Holdings Inc. (MDMA) current stock price?
As of the latest data, Pharmala Biotech Holdings Inc. stock price is CA$0.21, with a previous close of CA$0.17. Pharmala Biotech Holdings Inc. gained CA$0.04 in the last trading session, representing a 20.59% increase.
What is Pharmala Biotech Holdings Inc. (MDMA) current market capitalization?
Pharmala Biotech Holdings Inc. market cap is approximately 22.39 million.
What is Pharmala Biotech Holdings Inc. (MDMA) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.01.
Does Pharmala Biotech Holdings Inc. (MDMA) pay dividends?
No. Pharmala Biotech Holdings Inc. does not pay a dividend.
What is Pharmala Biotech Holdings Inc. (MDMA) beta (volatility) score?
Pharmala Biotech Holdings Inc. has a beta of 0.751, indicating lower volatility than the overall market.